minopafant
Small moleculeexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- Platelet activating factor receptorANTAGONIST
PTAFR antagonist
Chemistry & pharmacology
Loading structure…
SMILES
CCCCCCCCCCCCCCCCCCNC(=O)OC1CCN(C(=O)OC[C@H](COC(=O)N(Cc2cccc[n+]2CC)C(=O)c2ccccc2OC)OC)CC1.[Cl-]- Mol. weight
- 861.56 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2110618 ↗
- ChEMBLCHEMBL2104419 ↗
Also known as
- 1-ethyl-2-(n-(2-methoxy)benzoyl-n-(2-methoxy-3-(4-octadecylcarbamoyloxy)piperidinocarbonyloxypropyloxy)carbonyl)aminomethylpyridinium chloride
- e 5880
- e-5880
- e-5880
- e-5880
- minopafant
- minopafant